Reduction in Gal-9 levels after initiation of antitubercular treatment needs to be investigated further to determine the monitoring potential of Gal-9 levels in HIV/TB co-infection as was demonstrated in acute infections such as dengue and malaria (Chagan-Yasutan et al., 2013; Dembele et al., 2016). This evidence concerns the gene LGALS9 and malaria.